Explore all that Huvepharma, Inc. has to offer! Like us on Facebook and subscribe to our Youtube channel.
An effective vaccination program helps set your calves up for success.
August 28, 2018 (Peachtree City, GA) – Huvepharma, a fast-growing global pharmaceutical company focused on developing, manufacturing, and marketing human and animal health products, announces the acquisition of T-HEXX Animal Health, a division of Hydromer, Inc. The T-HEXX lines of products are based upon innovative hydrophilic polymer technologies for animal health, primarily in the dairy and equine markets.
October 1, 2018 (Peachtree City, GA) – Huvepharma®, a fast-growing global pharmaceutical company focused on developing, manufacturing, and marketing human and animal health products, announces the release of a conditional licensed vaccine for the prevention of pinkeye caused by Moraxella bovoculi in cattle.
The first FDA-approved generic monensin – available to U.S. beef, dairy, and goat producers as Monovet®90 from global animal health company Huvepharma® – has now also received FDA approval for combination use with other drug feed additive products in the manufacture of Type B and C medicated feeds.
